Get notified of page updates

Policy Archive Successful Effort

Establishment of National HBOC Week and Previvor Day

Hereditary Cancer Awareness

On September 15th, 2010, in a unanimous show of support, the U.S. House of Representatives voted in favor of a Resolution sponsored by Rep. Wasserman Schultz (FL-20) establish National Hereditary Breast and Ovarian Cancer Week and National Previvor Day. National HBOC week is now recognized as an annual event, beginning the last Sunday in September and ending the first Saturday in October. National Previvor Day occurs on the Wednesday of that week. 

The timing—the transition between National Ovarian Cancer Awareness Month (September) and National Breast Cancer Awareness Month (October)—demonstrates the link between these two cancers. It is estimated that up to 25% of ovarian cancers are due to hereditary factors and approximately 10% of breast cancers are hereditary. FORCE is proud to have spearheaded this initiative to bring attention to hereditary breast and ovarian cancer (HBOC) syndromes and to recognize their impact on the families affected.

Read the text of the resolution, H Res #1522. 

 

Update: With the growth of the hereditary cancer community and expansion of FORCE's mission to serve a broader population, National Hereditary Cancer Week was instituted in 2020.

Take Action Now BECOME AN ADVOCATE 2022 Priorities Advocacy Archive Public Policy Initiatives

News Briefs

12/6/2022 - Joined a broad range of stakeholders to urge Appropriations leaders to pass the FY23 Omnibus spending bill, and to include boosted funding for the National Institutes of Health (NIH) and our nation’s other research agencies.

11/28/2022 - Asked congressional leadership to include the Access to Genetic Counselor Services Act (H.R.2144/S.1450) in a year-end legislative package so that Medicare beneficiaries can better access genetic counseling services.

11/21/2022 - Joined the Defense Health Research Consortium in encouraging congressional leaders to enact the FY23 Defense Appropriations Act, to ensure full funding of the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs (CDMRP).

11/2/2022 - Urged congressional leaders to prioritize the Metastatic Breast Cancer Access to Care Act (H.R.3183/S.1312), which eliminates waiting periods for SSDI benefits and for Medicare coverage for individuals with metastatic breast cancer.

More